Go to Top

Institute of Cellular Therapies

Institute of Cellular Therapies

Noida, India   |   Accreditation: none listed 

J 3

Sector 41

info@dendriticcellresearch.com

00911202500111, 00919911862601

 

Features:

The Denvax is dendritic cell-based cancer immunotherapy for solid cancers in various stages of the disease. It is autologous treatment, which involves patient’s own mononuclear cells transformed into cancer-specific dendritic cells.

Designed to be specific, Denvax targets only the cancer cells without harming the healthy ones. It is safe and effective and works best to prevent relapse and recurrences, the major cause of mortality and morbidity.

Denvax helps in correcting the failed immune surveillance and teaches the immune system to recognize and kill cancer cells.

Cancer treatment modalities like surgical resection, chemotherapy and/or radiation are mostly ineffective in controlling the micrometastasis. Micrometastases are single tumor cells or clusters of cells shed by solid cancers and disseminated in various organs of the body. Micrometastases have a pronounced clinical effect, are hard to detect and can be the starting point of recurrence of cancer.

Denvax targets the micrometastais and destroys the disseminated cancer cells, thereby preventing its development, slowing the spread of cancer and improving the life expectancy.

 

Specialties:

Customized Cancer Immunotherapy (Dendritic Cell Therapy in solid cancers)

Specialists:

Dendritic cell therapy experts

Travel Information:

Indira Gandhi International Airport, New Delhi

Insurance Accepted:

Yes